Change Page: Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control

BMJ 2007; 335 doi: (Published 20 September 2007) Cite this as: BMJ 2007;335:0-a

An editorial oversight led this Practice article by Peter J Barnes (BMJ 2007;335:513, 8 Sep, doi: 10.1136/bmj.39273.537778.AD) to claim that the author had no competing interests. In fact, in his original manuscript he had declared: “PB receives research funding from AstraZeneca, GlaxoSmithKline, Novartis, Pfizer, and Boehringer Ingelheim, all of whom are involved in the development of asthma therapies.”

View Abstract